Javier Amu,m.D. Professional Corporation

Javier Amu,m.D. Professional Corporation was paid $10.01M by Medicaid between Jan 2018 and Dec 2024, across 57 billing codes. Its largest line is T1015, a visit at a community health center or clinic (one all-in rate) — 93% of everything it billed.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	37,394	$1.49M
2019	59,613	$1.63M
2020	51,332	$1.16M
2021	49,456	$1.60M
2022	47,490	$1.22M
2023	51,147	$1.60M
2024incomplete	34,996	$1.31M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
T1015	A visit at a community health center or clinic (one all-in rate)Clinic visit/encounter, all-inclusive	93%	108,310	85,492	$9.27M
99213	Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity	3.9%	93,952	68,498	$394K
87426	Infectious agent antigen detection, SARS-CoV-2 (COVID-19)	<1%	9,208	8,672	$44K
0002A		<1%	589	341	$33K
0071A		<1%	555	325	$31K
0072A		<1%	487	313	$28K
0001A		<1%	505	281	$27K
99392	Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years)	<1%	5,166	4,658	$25K
99393	Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years)	<1%	4,552	4,087	$25K
99391	Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year)	<1%	3,925	3,449	$15K
99394	Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years)	<1%	1,897	1,672	$15K
92551		<1%	11,147	10,326	$13K

45 more codes

96110	Developmental screening, with scoring and documentation, per standardized instrument	<1%	2,187	$13K
87880	Infectious agent antigen detection by immunoassay; Streptococcus, group A	<1%	6,031	$8K
99212	Office or other outpatient visit for the evaluation and management of an established patient, straightforward	<1%	2,527	$8K
G2023	Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	<1%	5,320	$7K
85018		<1%	21,771	$7K
0003A		<1%	120	$7K
90686		<1%	7,016	$7K
81000		<1%	13,442	$4K
99173		<1%	10,733	$4K
90670		<1%	2,847	$2K
0081A		<1%	29	$2K
90651		<1%	972	$2K
99188		<1%	923	$2K
90648		<1%	2,240	$2K
17110		<1%	183	$2K
90734		<1%	515	$1K
90677		<1%	235	$1K
90680		<1%	1,817	$1K
90716		<1%	1,202	$1K
90707		<1%	1,184	$1K
90723		<1%	1,553	$1K
90633		<1%	1,260	$1K
0082A		<1%	16	$1K
96127		<1%	1,636	$1K
86580		<1%	890	$760.63
90688		<1%	297	$662.70
94640	Pressurized or nonpressurized inhalation treatment for acute airway obstruction	<1%	289	$404.60
99000		<1%	1,445	$390.66
90697		<1%	559	$324.00
99203	Doctor's office visit, new patient (routine)	<1%	86	$271.88
99381		<1%	180	$265.61
90661		<1%	122	$238.96
90700		<1%	237	$190.80
90674		<1%	83	$179.40
99461		<1%	19	$162.00
83655		<1%	166	$158.60
90715		<1%	139	$130.50
90696		<1%	171	$130.50
96150		<1%	184	$99.46
36400		<1%	29	$96.50
94760		<1%	244	$85.10
90620		<1%	53	$81.90
G8510	Screening for depression is documented as negative, a follow-up plan is not required	<1%	62	$52.33
99383		<1%	17	$49.35
36416		0%	104	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialAMU, JAVIER (MEDICAL DIRECTOR)